405 filings
Page 8 of 21
6-K
vyrd tqfb3
23 Apr 18
Intellipharmaceutics Receives Delisting Determination
12:00am
6-K
jqlvefpow68b9vgdmf
16 Apr 18
Annual & Special Meeting of Shareholders
12:00am
6-K
8wiq8i mkrs6
16 Apr 18
Primary Document
12:00am
D
6jth2w 0b39ek
3 Apr 18
$1.01M in options / securities to be acquired, sold $1.01M, 5 investors
12:00am
6-K
nlq1 mglskb92iu2k9k
29 Mar 18
Primary Document
12:00am
6-K
1ahja
22 Mar 18
Primary Document
12:00am
6-K
xxg0hgx2
21 Mar 18
Intellipharmaceutics Announces Closing of US$ 1.8 Million Financing
12:00am
D
vgq4u7o qa
21 Mar 18
$1.97M in options / securities to be acquired, sold $1.97M, 5 investors
12:00am
SC 13G/A
gp7nn9ecp zy7
20 Mar 18
Intellipharmaceutics International Inc.
12:00am
424B5
40933g8f2yh8j6a
20 Mar 18
Prospectus supplement for primary offering
12:00am
6-K
o2l8ssez
20 Mar 18
Primary Document
12:00am
SC 13G
95y 3nt54j10nvb4fg7g
20 Mar 18
Intellipharmaceutics International Inc.
12:00am
6-K
i8qrtjajkioljnpmz076
19 Mar 18
Intellipharmaceutics Announces Closing of US$ 3.5 Million Financing
12:00am
6-K
li1i9shcz4qk432 qs
19 Mar 18
Intellipharmaceutics Announces US$ 1.8 Million Registered Direct Offering
12:00am
6-K
gtr80yun4hk7 xtri
16 Mar 18
Primary Document
12:00am
424B5
adz9a76
16 Mar 18
Prospectus supplement for primary offering
12:00am
424B3
pzvezqsa pqf
14 Mar 18
Prospectus supplement
12:00am
6-K
wkrv12qhtx4
14 Mar 18
Intellipharmaceutics Announces US$3.5 Million Registered Direct Offering
12:00am
6-K
07ohcxd
1 Mar 18
Primary Document
12:00am